AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field ‘much less crowded than it seems’

AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field ‘much less crowded than it seems’
aarmstrong
Mon, 04/17/2023 – 13:43